Rankings
▼
Calendar
OCGN FY 2012 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$787M
FY 2012 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$26,000
Gross Profit
$26,000
100.0% margin
Operating Income
-$15M
-57569.2% margin
Net Income
-$17M
-65134.6% margin
EPS (Diluted)
$-79.65
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$14,000
Balance Sheet
Total Assets
$21M
Total Liabilities
$41M
Stockholders' Equity
-$20M
Cash & Equivalents
$15M
← FY 2013
All Quarters